{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:02:34Z","timestamp":1782936154291,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T00:00:00Z","timestamp":1778976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T00:00:00Z","timestamp":1778976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000008","name":"David and Lucile Packard Foundation","doi-asserted-by":"publisher","award":["2013-39274"],"award-info":[{"award-number":["2013-39274"]}],"id":[{"id":"10.13039\/100000008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI185808"],"award-info":[{"award-number":["R21AI185808"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK007737-30"],"award-info":[{"award-number":["DK007737-30"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Biomed Eng"],"DOI":"10.1007\/s10439-026-04117-6","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T17:33:47Z","timestamp":1779039227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Droplet Digital PCR Assay for Quantification of Bacteriophage Viral Vector Titer and Purity"],"prefix":"10.1007","author":[{"given":"Peter J.","family":"Voorhees","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronni M.","family":"Ponek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie D.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5293-9296","authenticated-orcid":false,"given":"Samuel K.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,17]]},"reference":[{"key":"4117_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","volume":"186","author":"SA Strathdee","year":"2023","unstructured":"Strathdee, S. A., G. F. Hatfull, V. K. Mutalik, and R. T. Schooley. Phage therapy: From biological mechanisms to future directions. Cell. 186:17\u201331, 2023.","journal-title":"Cell."},{"key":"4117_CR2","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/femsre\/fuaa017","volume":"44","author":"DP Pires","year":"2020","unstructured":"Pires, D. P., A. R. Costa, G. Pinto, L. Meneses, and J. Azeredo. Current challenges and future opportunities of phage therapy. FEMS Microbiol. Rev. 44:684\u2013700, 2020.","journal-title":"FEMS Microbiol. Rev."},{"key":"4117_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1128\/MMBR.00069-15","volume":"80","author":"DP Pires","year":"2016","unstructured":"Pires, D. P., S. Cleto, S. Sillankorva, J. Azeredo, and T. K. Lu. Genetically engineered phages: a review of advances over the last decade. Microbiol. Mol. Biol. Rev. 80:523\u2013543, 2016.","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"4117_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jconrel.2020.06.016","volume":"326","author":"PJ Voorhees","year":"2020","unstructured":"Voorhees, P. J., C. Cruz-Teran, J. Edelstein, and S. K. Lai. Challenges & opportunities for phage-based in situ microbiome engineering in the gut. J. Control. Release. 326:106\u2013119, 2020.","journal-title":"J. Control. Release."},{"key":"4117_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.addr.2016.04.032","volume":"105","author":"M Mimee","year":"2016","unstructured":"Mimee, M., R. J. Citorik, and T. K. Lu. Microbiome therapeutics\u2014advances and challenges. Adv. Drug Deliv. Rev. 105:44\u201354, 2016.","journal-title":"Adv. Drug Deliv. Rev."},{"key":"4117_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.tig.2016.01.005","volume":"32","author":"RU Sheth","year":"2016","unstructured":"Sheth, R. U., V. Cabral, S. P. Chen, and H. H. Wang. Manipulating bacterial communities by in situ microbiome engineering. Trends Genet. 32:189\u2013200, 2016.","journal-title":"Trends Genet."},{"key":"4117_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/genes9070351","volume":"9","author":"HL Lee","year":"2018","unstructured":"Lee, H. L., H. Shen, I. Y. Hwang, et al. Targeted approaches for in situ gut microbiome manipulation. Genes. 9:10, 2018.","journal-title":"Genes"},{"key":"4117_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/msystems.00013-20","volume":"5","author":"BB Hsu","year":"2020","unstructured":"Hsu, B. B., J. C. Way, and P. A. Silver. Stable neutralization of a virulence factor in bacteria using temperate phage in the mammalian gut. MSystems. 5:1, 2020.","journal-title":"MSystems."},{"key":"4117_CR9","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41586-024-07681-w","volume":"632","author":"AK Br\u00f6del","year":"2024","unstructured":"Br\u00f6del, A. K., L. H. Charpenay, M. Galtier, et al. In situ targeted base editing of bacteria in the mouse gut. Nature. 632:877\u2013884, 2024.","journal-title":"Nature"},{"key":"4117_CR10","first-page":"1","volume":"2025","author":"ZR Baker","year":"2025","unstructured":"Baker, Z. R., Y. Zhang, H. Zhang, et al. Sustained in situ protein production and release in the mammalian gut by an engineered bacteriophage. Nat. Biotechnol. 2025:1\u201310, 2025.","journal-title":"Nat. Biotechnol."},{"key":"4117_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-1-61779-095-9_11","volume":"737","author":"JF Wright","year":"2011","unstructured":"Wright, J. F., and O. Zelenaia. Vector characterization methods for quality control testing of recombinant adeno-associated viruses. Methods Mol. Biol. 737:247\u2013278, 2011.","journal-title":"Methods Mol. Biol."},{"key":"4117_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/genes12040601","volume":"12","author":"C Martinez-Fernandez de la Camara","year":"2021","unstructured":"Martinez-Fernandez de la Camara, C., M. E. McClements, and R. E. Maclaren. Accurate quantification of AAV vector genomes by quantitative PCR. Genes. 12:1, 2021.","journal-title":"Genes"},{"key":"4117_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-1-4939-9139-6_4","volume":"1950","author":"J Sanmiguel","year":"2019","unstructured":"Sanmiguel, J., G. Gao, and L. H. Vandenberghe. Quantitative and digital droplet-based AAV genome titration. Methods Mol. Biol. 1950:51, 2019.","journal-title":"Methods Mol. Biol."},{"key":"4117_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.omtm.2018.07.004","volume":"10","author":"A Fran\u00e7ois","year":"2018","unstructured":"Fran\u00e7ois, A., M. Bouzelha, E. Lecomte, et al. Accurate titration of infectious AAV particles requires measurement of biologically active vector genomes and suitable controls. Mol. Ther. Methods Clin. Dev. 10:223, 2018.","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"4117_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.omtm.2020.06.002","volume":"18","author":"SJ Aronson","year":"2020","unstructured":"Aronson, S. J., R. S. Bakker, S. Moenis, et al. A quantitative in vitro potency assay for adeno-associated virus vectors encoding for the UGT1A1 transgene. Mol. Ther. Methods Clin. Dev. 18:250\u2013258, 2020.","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"4117_CR16","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/gt.2008.65","volume":"15","author":"JF Wright","year":"2008","unstructured":"Wright, J. F. Manufacturing and characterizing AAV-based vectors for use in clinical studies. Gene Ther. 15:840\u2013848, 2008.","journal-title":"Gene Ther."},{"key":"4117_CR17","first-page":"58267","volume":"2018","author":"A Saragliadis","year":"2018","unstructured":"Saragliadis, A., T. Trunk, and J. C. Leo. Producing gene deletions in Escherichia coli by P1 transduction with excisable antibiotic resistance cassettes. J. Vis. Exp. 2018:58267, 2018.","journal-title":"J. Vis. Exp."},{"key":"4117_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1021\/acssynbio.0c00467","volume":"10","author":"M Tridgett","year":"2021","unstructured":"Tridgett, M., M. Ababi, A. Osgerby, R. Ramirez Garcia, and A. Jaramillo. Engineering bacteria to produce pure phage-like particles for gene delivery. ACS Synth. Biol. 10:107\u2013114, 2021.","journal-title":"ACS Synth. Biol."},{"key":"4117_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cels.2015.08.013","volume":"1","author":"H Ando","year":"2015","unstructured":"Ando, H., S. Lemire, D. P. Pires, and T. K. Lu. Engineering modular viral scaffolds for targeted bacterial population editing. Cell Syst. 1:187\u2013196, 2015.","journal-title":"Cell Syst."},{"key":"4117_CR20","unstructured":"Bio-Rad Laboratories: Droplet Digital TM PCR Droplet Digital TM PCR Applications Guide. No date."},{"key":"4117_CR21","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.molcel.2017.04.025","volume":"66","author":"I Yosef","year":"2017","unstructured":"Yosef, I., M. G. Goren, R. Globus, S. Molshanski-Mor, and U. Qimron. Extending the host range of bacteriophage particles for DNA transduction. Mol. Cell. 66:721-728.e3, 2017.","journal-title":"Mol. Cell."},{"key":"4117_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-57221-0","volume":"10","author":"T Holtzman","year":"2020","unstructured":"Holtzman, T., R. Globus, S. Molshanski-Mor, A. Ben-Shem, I. Yosef, and U. Qimron. A continuous evolution system for contracting the host range of bacteriophage T7. Sci. Rep. 10:1\u20138, 2020.","journal-title":"Sci. Rep."},{"key":"4117_CR23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.copbio.2021.02.006","volume":"68","author":"M Dunne","year":"2021","unstructured":"Dunne, M., N. S. Prokhorov, M. J. Loessner, and P. G. Leiman. Reprogramming bacteriophage host range: design principles and strategies for engineering receptor binding proteins. Curr. Opin. Biotechnol. 68:272\u2013281, 2021.","journal-title":"Curr. Opin. Biotechnol."},{"key":"4117_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-02217-x","volume":"7","author":"SC Taylor","year":"2017","unstructured":"Taylor, S. C., G. Laperriere, and H. Germain. Droplet digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication quality data. Sci. Rep. 7:1\u20138, 2017.","journal-title":"Sci. Rep."},{"key":"4117_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.xpro.2021.100697","volume":"2","author":"MC Bichet","year":"2021","unstructured":"Bichet, M. C., R. Patwa, and J. J. Barr. Protocols for studying bacteriophage interactions with in vitro epithelial cell layers. STAR Protoc. 2:1, 2021.","journal-title":"STAR Protoc."},{"key":"4117_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jviromet.2018.05.007","volume":"259","author":"NM Morella","year":"2018","unstructured":"Morella, N. M., S. C. Yang, C. A. Hernandez, and B. Koskella. Rapid quantification of bacteriophages and their bacterial hosts in vitro and in vivo using droplet digital PCR. J. Virol. Methods. 259:18\u201324, 2018.","journal-title":"J. Virol. Methods."},{"key":"4117_CR27","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.3389\/fmicb.2020.594868","volume":"11","author":"N \u00c1cs","year":"2020","unstructured":"\u00c1cs, N., M. Gambino, and L. Br\u00f8ndsted. Bacteriophage enumeration and detection methods. Front. Microbiol. 11:2662, 2020.","journal-title":"Front. Microbiol."},{"key":"4117_CR28","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1021\/acs.analchem.5b03238","volume":"88","author":"FU Dalmira","year":"2016","unstructured":"Dalmira, F. U., P. U. Melina, V. T. Jos\u00e9-Benigno, L. F. Josefina, G. E. Raymundo, and A. S. Abraham. Development, optimization, and evaluation of a duplex droplet digital PCR assay to quantify the T-nos\/hmg copy number ratio in genetically modified maize. Anal. Chem. 88:812\u2013819, 2016.","journal-title":"Anal. Chem."},{"key":"4117_CR29","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1021\/acssynbio.1c00036","volume":"10","author":"CN Lam","year":"2021","unstructured":"Lam, C. N., M. G. Mehta-Kolte, N. Martins-Sorenson, et al. A tail fiber engineering platform for improved bacterial transduction-based diagnostic reagents. ACS Synth. Biol. 10:1292, 2021.","journal-title":"ACS Synth. Biol."},{"key":"4117_CR30","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/15476286.2018.1514235","volume":"16","author":"O Auster","year":"2019","unstructured":"Auster, O., R. Globus, I. Yosef, and U. Qimron. Optimizing DNA transduction by selection of mutations that evade bacterial defense systems. RNA Biol. 16:595, 2019.","journal-title":"RNA Biol."},{"key":"4117_CR31","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1128\/AEM.00139-10","volume":"76","author":"LH Damelin","year":"2010","unstructured":"Damelin, L. H., D. Mavri-Damelin, T. R. Klaenhammer, and C. T. Tiemessen. Plasmid transduction using bacteriophage \u03c6adh for expression of CC chemokines by Lactobacillus gasseri ADH. Appl. Environ. Microbiol. 76:3878, 2010.","journal-title":"Appl. Environ. Microbiol."},{"key":"4117_CR32","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1093\/nar\/gkae1266","volume":"53","author":"PJ Voorhees","year":"2025","unstructured":"Voorhees, P. J., X. Chang, and S. K. Lai. Defining serine tRNA knockout as a strategy for effective repression of gene expression in organisms with a recoded genome. Nucleic Acids Res. 53:1266, 2025.","journal-title":"Nucleic Acids Res."}],"container-title":["Annals of Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10439-026-04117-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10439-026-04117-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10439-026-04117-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:18:02Z","timestamp":1782929882000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10439-026-04117-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,17]]},"references-count":32,"alternative-id":["4117"],"URL":"https:\/\/doi.org\/10.1007\/s10439-026-04117-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.11.20.624577","asserted-by":"object"}]},"ISSN":["0090-6964","1573-9686"],"issn-type":[{"value":"0090-6964","type":"print"},{"value":"1573-9686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,17]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"P.J.V. and S.K.L. are inventors of a provisional patent application covering the use of genetically recoded organisms to produce specific viral vectors. The terms of these arrangements are managed by UNC-CH in accordance with its COI policies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}